Skip to Content

Velkov Laboratory

Anti-infective Pharmacology

Welcome to the Velkov Lab

The Anti-infective Pharmacology Laboratory investigates several aspects of antibiotic pharmacology, including their mode of action, chemistry, structure-activity relationships and toxicity, aiming to create new antimicrobials to address antibiotic resistance.

We're part of the Monash Biomedicine Discovery Institute, and a member of the Infection Program, and the Department of Pharmacology.

Professor Tony Velkov

My global research connections, partners and funding can be viewed on my Monash Research Profile.

If you are a student interested in doing research in our lab, visit Supervisor Connect.

Click the links below to connect with me on ORCID and Google Scholar.

Our research

Due to a marked decline in the discovery of new antibiotics over the past few decades, the world is now facing an enormous threat from the emergence of bacteria that are resistant to all available antibiotics. Our lab aims to address antibiotic resistance by creating new antimicrobials.

  • Development of novel teixobactin-lipopeptide hybrid antibiotics

  • Function and biosynthetic origin of octapeptin antibiotics

  • Pharmacology and neurotoxicity of CNS polymyxins

  • Systems pharmacology of novel Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) modulator/corrector drugs

Lab members

We are committed to excellence in research.

Publications

View our chosen highlighted key publications.

Read more

News

We want to share our research discoveries & successes with you.

Read more

Join Our Lab

We're always interested in collaborating with bright and motivated researchers, clinicians and industry. Whether you want to research, study or partner with us to accelerate our discoveries, find out about the work we do.

Find out more